Figure S1 from Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study
Year: 2023
Type: other
Abstract: Fig S1. Survival analysis of Group 3 medulloblastoma, with groups separation based on FKBP5 (A), MAK16 (B), RRP15 (C) and PALMD (D) median mRNA expression in previously published cohorts(8). E) Density plot representing protein half-lives in mouse brain (26). Grey line represents the mean protein half-life.
Authors: Alberto Delaidelli, Christopher Dunham, Mariarita Santi, Gian Luca Negri, Joanna Triscott, Olga Zheludkova, Andrey Golanov, Marina Ryzhova, Konstantin Okonechnikov, Daniel Schrimpf, Damian Stichel, David W. Ellison, Andreas von Deimling, Marcel Kool, Stefan M. Pfister, Vijay Ramaswamy, Andrey Korshunov, Michael D. Taylor, Poul H. Sorensen
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362432235